ReviewCurrent oncology reports2022

Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission.

Ruth Stuckey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.